Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · Real-Time Price · USD

1.210

-0.250 (-17.12%)

At close: Sep 17, 2025, 4:00 PM EDT

1.200

-0.010 (-0.83%)

After-hours: Sep 17, 2025, 7:17 PM EDT

Lexaria Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 17, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	2015 - 2019
Market Capitalization	24	62	8	18	35	31	Upgrade
Market Cap Growth	-56.43%	627.66%	-51.77%	-50.18%	13.53%	-42.60%	Upgrade
Enterprise Value	22	53	5	10	27	29	Upgrade
Last Close Price	1.46	3.91	1.05	2.96	6.22	10.38	Upgrade
PS Ratio	40.37	133.15	37.56	68.97	48.92	98.93	Upgrade
PB Ratio	5.14	8.07	3.17	2.31	2.71	12.55	Upgrade
P/TBV Ratio	5.32	8.22	3.29	2.36	2.74	13.95	Upgrade
EV/Sales Ratio	36.19	114.33	21.58	39.44	37.19	92.55	Upgrade
Debt / Equity Ratio	0.02	0.02	0.06	0.01	0.01	0.06	Upgrade
Asset Turnover	0.07	0.08	0.04	0.02	0.09	0.11	Upgrade
Inventory Turnover	-	-	-	2.11	2.39	0.81	Upgrade
Quick Ratio	3.35	6.10	5.99	32.79	78.90	7.20	Upgrade
Current Ratio	3.90	7.18	8.04	35.96	81.18	8.53	Upgrade
Return on Equity (ROE)	-152.89%	-112.36%	-130.18%	-71.35%	-73.16%	-166.85%	Upgrade
Return on Assets (ROA)	-84.74%	-59.56%	-73.59%	-39.21%	-44.17%	-94.23%	Upgrade
Return on Capital (ROIC)	-93.60%	-66.91%	-76.32%	-39.70%	-44.99%	-101.11%	Upgrade
Earnings Yield	-42.51%	-9.38%	-78.45%	-41.27%	-11.39%	-12.63%	Upgrade
FCF Yield	-36.45%	-8.09%	-69.63%	-27.98%	-11.28%	-8.41%	Upgrade
Buyback Yield / Dilution	-62.48%	-87.24%	-12.38%	-34.02%	-58.34%	-6.95%	Upgrade

Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q